ACELL INC
ACLL
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Medical Equipment, Supplies & Distribution
2020-06-26
Public Filing
View Prospectus
Pending
Offering
Price Range: Pending
Shares to be Issued: Pending
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: Pending
Listed
About ACLL
ACell, Inc. is a regenerative medicine company. The Company is focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. Its products utilize its porcine urinary bladder matrix platform technology. It manufactures extracellular matrix (ECM), products that utilize porcine urinary bladder matrix (UBM). It markets MicroMatrix, a particulate formulation, and Cytal Wound Matrix products, in sheet formulations, for the management of acute, surgical, chronic and tunneling wounds and partial thickness burns. It also markets Gentrix Surgical Matrix products, in sheet formulations, for the reinforcement of soft tissue in certain surgical applications, such as for hernia repair.
More

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of ACELL INC stock information, including NASDAQ:ACLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACLL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACLL stock methods without spending real money on the virtual paper trading platform.